Position in COGT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$239,446
+$11,017 QoQ
Shares Held
6,221
-3.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 202649 WEALTH MANAGEMENT, LLC holds $1,082,360 across 7 Biotechnology names. COGT ranks #1 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
This page
|
6,221 | $239,446 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
2,513 | $210,890 | |
| 3 | ZNTL |
Zentalis Pharmaceuticals, Inc.
|
66,401 | $155,378 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
10,018 | $155,279 | |
| 5 | AURA |
Aura Biosciences, Inc.
|
21,704 | $145,199 | |
| 6 | RLAY |
Relay Therapeutics, Inc.
|
11,029 | $109,738 | |
| 7 | BCYC |
Bicycle Therapeutics PLC
|
14,317 | $66,430 |
All Filings in COGT
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $239,446 | 6,221 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $228,429 | 6,431 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $144,217 | 10,043 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $111,347 | 15,508 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $78,061 | 13,032 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $98,139 | 12,582 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $135,885 | 12,582 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $106,066 | 12,582 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $88,280 | 13,137 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $64,097 | 10,901 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||